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The development of ECL-Plex CyDye-conjugated secondary antibodies allows the advancement
of conventional Western blotting, opening up possibilities for highly sensitive and quantitative
protein confirmation and identification. We report a novel proteomic method to simultaneously
visualise the total protein profile as well as the specific immunodetection of an individual protein
species by combining cyanine CyDye pre-labelled proteins and antibody immunoblotting. This
technique proposes to revolutionise both 2-D immunoprobing and protein confirmation follow-
ing MS analysis.
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Western immunoblotting facilitates the interaction of
immobilised proteins with specific polyclonal or monoclonal
antibodies, identifying the corresponding immunoreactive
protein. This technique, developed in the 1970s, is still
widely used as a rapid and relatively straightforward method
of protein identification [1]. Conventional immunodetection,
however, does not move easily from 1-D to 2-DE. Two-
dimensional gels are able to display simultaneously up to
2000 protein products on a single gel [2]. Immunoblotting
for a specific protein species can therefore be extremely dif-
ficult, as it is often impossible to say definitively which spot
on the 2-D gel correlates with the immunoreactive protein. A
number of methods for pre- and post-staining oftotal protein
attempt to address this problem. These include gel-staining
techniques such as CBB and silver stain along with fluores-
cence-based methods such as SYPRO-Ruby and Deep Pur-
ple. Pre-staining does present an overall impression of the
total protein profile but many of these methods are incom-
patible with downstream immunoblotting analysis and,
therefore, must be removedfrom the blot membrane prior to
antibody detection. Protein stains such as Amido black,
Ponceau-S, Fast green FC, Colloidal gold and India ink all
successfully stain proteins bound to immunoblot mem-
branes but are again lost during antibody incubation [3].
The method described here, based on the use of the
recently developed ECL Plex-CyDye immunoblot detection
system (GE Healthcare, Uppsala, Sweden), allows the
simultaneous immunodetection of an individual protein
species in conjunction with visualisation of the total protein
profile. Protein samples are initially pre-labelled with the
charge-matched “minimal labelling” cyanine CyDye reagents
(GE Healthcare), Cy3 and Cy5, and then separated by 1-D or
2-DE. Following electrophoresis, the proteins are transferred
by electroblotting onto membranes and probed with a spe-
cific primary antibody of choice. Subsequent incubation of
the membrane with wavelength-specific ECL Plex fluor-
labelled species-specific secondary antibodies (GE Health-
care) enables the visualisation of both the total protein
expression profile and the specific immunoreactive pro-
tein(s). This technique is not only highly sensitive, as a con-
sequence of the use of CyDye labelling, but also reduces the
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Protein spots of interest can then be easily correlated with
other analytical or micro-preparative 2-D gels for further dif-
ferential expression analysis and/or protein identification by
MS.
Human left ventricular heart tissue (0.2 g) was ground to
a fine powder with the aid of liquid nitrogen and a pestle and
mortar. Ground tissue (0.25 g) was immediately added to
DIGE compatible lysis buffer (9.5 M urea w/v, 2% CHAPS
w/v, and 20 mM Tris w/v pH 8.0–8.5) and incubated at room
temperature for 1 h. Protein samples were sonicated on ice
for 3610-s bursts. Following centrifugation at 140006gav
for 30 min, protein fractions were collected, aliquoted and
stored at -807C until further use. All preparative steps were
performed at 0-47C in the presence of a protease inhibitor
(Roche complete protease inhibitor cocktail tablets) to pre-
vent proteolytic degradation. Protein concentration was
determined using the Bradford dye-binding assay [4].
Minimal CyDye labelling (GE Healthcare) was per-
formed at a concentration of 25 mg of protein/200 pmol of
CyDye for 1-DE. Due to the separation capabilities of 2-DE
a minimum protein loading of 150 mg/1000 pmol of CyDye
was required for 2-DE analysis. Protein loadings of 300 and
600 mg were labelled at the same ratio. Labelled Cy 3 and Cy
5 samples were incubated on ice for 30 min in the dark.
The labelling reaction was terminated by the addition of
10 mM lysine. After a brief spin, samples were incubated
on ice in the dark for 10 min. Labelled protein fractions
were utilised immediately for further analysis or otherwise
stored at 2207C. Protein samples analysed by 1-D SDS-
PAGE were combined with an equal volume of Laemmli
buffer (Bio-Rad, Hemel-Hampstead, UK) while 2-DE sam-
ples were combined with an equal volume of 2X lysis buf-
fer (9.5 M urea, 2% CHAPS, 2% DTTand 1.6% Pharmalyte
pH 3–10) followed by in-gel rehydration overnight prior to
IEF.
1-D SDS-PAGE was carried out using the Bio-Rad mini-
gel system on 4–20% gradient gels (Pierce, IL, USA) accord-
ing to Laemmli et al. [5]. Pre-labelled protein samples were
combined with an equal volume of Laemmli sample buffer
(Bio-Rad), and separated at 160 V for 1.5 h using the Bio-Rad
mini-Protean III system. For 2-DE, 150, 300 and 600 mgo f
human heart left ventricle protein samples were diluted in
rehydration solution (8 M urea, 0.5% w/v CHAPS, 0.2% w/v
DTT and 0.2% w/v Pharmalyte pH 3–10) and applied to
24-cm IPG strips (pH 3–10, non-linear (NL), GE Healthcare).
Strips were rehydrated overnight at room temperature using
an in-gel rehydration method [6]. The sample was then sub-
jected to IEFat 0.05 mA/IPG strip for 72000 Vh at 207C. The
strips were equilibrated in 6 M urea, containing 30% v/v
glycerol, 2% w/v SDS, 0.05 M Tris-HCl, pH 8.8 and 0.01%
w/v Bromophenol blue with the addition of 1% w/v DTT for
15 min. Subsequently, the strips were equilibrated in the
same buffer without DTT but with the addition of 4.8% w/v
iodoacetamide for 15 min [7]. The second dimension was
carried out overnight using a Bio-Rad Protean Plus Dodeca
Cell system at 1 W/gel at 157C and was terminated when the
dye front had just migrated offthe lower end ofthe gels. Gels
were subsequently scanned using a Typhoon variable mode
imager 9400 (GE Healthcare).
SDS-PAGE gels were electrophoretically transferred onto
Hybond NC membranes (GE Healthcare) using a Protean
blotting system (Bio-Rad) at 100 V for 1 h in transfer buffer
(0.2 mM Tris, 2.5 mM glycine and 20% methanol). Immedi-
ately after 2-DE, the gels were equilibrated in buffer (20 mM
Tris base, 150 mM glycine pH 8.3) with gentle agitation at
room temperature for 30 min. It is necessary to separately
soak the NC and filter paper in equilibration buffer to avoid
the transfer of artefacts to the membrane. The separated
proteins were then transferred by semi-dry blotting to
Hybond NC membranes for 2 h at 0.8 mA/cm
2. Membranes
were blocked for 2 h at room temperature in PBS containing
5% BSA and then incubated overnight in anti-Hsp 27 mAb
(SPA-800, Stressgen) (1:800 dil) in PBST (PBS, 0.1% Tween
20). Membranes were washed twice in PBSTand then incu-
bated in either ECL Plex goat-anti-mouse IgG, Cy 3 or goat-
anti-rabbit IgG, Cy 5-conjugated secondary antibody (GE
Healthcare) (1:2000 dil) for 1.5 h in PBST protected from
light. After incubation in secondary antibodies, blots were
washed twice in PBST for 10 min each, followed by two
washes in PBS while protected from light. All membranes
and immunoblots were visualised at each stage using a
Typhoon variable mode imager 9400 with a pixel volume at
40000–60000 for all scans. It is also important to use lint-
free tissue throughout the experimental protocol especially
for membrane storage.
To confirm Hsp 27 immunodetection, tryptic peptides
were analysed using an Applied Biosystems 4700 Proteomics
Analyser MALDI-TOF-TOF mass spectrometer using
10 mg/mL CHCA as the matrix. Mass spectra were acquired
in the reflector mode and the peptide sequences were con-
firmed by MS/MS of selected precursors. The precursor ion
masses and the masses of the daughter ions from MS/MS
experiments were scanned against the Swiss-Prot database
using MASCOT Search Software incorporated in the GPS
Explorer ™ v3.5 software. The following search parameters
were employed. The UniProt (release 6.0) Swiss-Prot non-
redundant database and the human taxonomy were used for
all searches. Methionine oxidation and cysteine carboxy-
amidomethylation were specified as variable modifications
and a maximum of one missed cleavage site was allowed.
The precursor tolerance was set at 150 ppm and the MS/MS
fragment tolerance was set at 0.25 Da.
The work describedhere attempts to address not only the
problems associated with conventional non-quantitative
immunoblotting but also those associated with protein spot
confirmation following fluorescent gel electrophoresis and
its subsequent software analysis. As seen in Fig. 1, human
left ventricular heart proteins were initially pre-labelled with
both Cy3 and Cy5 CyDyes and separated according to
molecular mass by 1-D SDS-PAGE. Separated proteins were
then transferred onto NC membranes followed by immuno-
detection with Hsp 27 mAb. Hsp 27 is a known cardiac heat
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Figure 1. ECL Plex 1-D CyDye
blotting. ECL Plex human left
ventricular heart fractions pre-
labelled with Cy3 and Cy5
CyDyes were electrophoretically
separated on a 1-D 4–20% gra-
dient gel (A). Following protein
transfer onto NC membranes,
(B), blots were probed with Hsp
27 mAb and visualised with Cy5
and Cy3 secondary conjugated
antibodies (C). Flour-labelled
ECL Plex rainbow molecular
mass markers were employed
to correctly identify labelled
proteins. All gels and mem-
branes were visualised using
the Typhoon variable mode
imager.
shock protein and has been investigated extensively in
previous work carried out by this research group [8].
Incubation with CyDye-conjugated secondary antibodies
allows the visualisation of both total protein expression
and specific antibody-CyDye-labelled proteins. As seen in
Fig. 1C, the sensitivity of the goat-anti-mouse IgG Cy3
secondary is inferior to its anti-mouse Cy5 counterpart,
therefore the Cy3 pre-labelling followed by the anti-mouse
Cy5 secondary combination was used in all subsequent
analysis.
Protein fractions pre-labelled with Cy3 CyDye were
subjected to 2-DE at loading concentrations of 150, 300
and 600 mg (Fig. 2), transferred onto NC membranes,
i n c u b a t e dw i t hH s p2 7m A b ,a n dv i s u a l i s e dw i t hC y 5 -
conjugated secondary antibody. As seen in Fig. 2, total
p r o t e i ne x p r e s s i o ni so v e r l a i dw i t ht h ei m m u n o l a b e l l e d
Hsp 27 protein spots. These images can also be viewed
separately by selecting the specific fluor channel for each
CyDye (Fig. 2). The multiple immunodetected spots
shown in Fig. 2, were manually excised for convenience
from a silver-stained micro-preparative 2-D gel. However,
it is possible to excise spots from fluorescently stained
gels, e.g. SYPRO Ruby via a robotics cutter. Spots were
subsequently digested with trypsin and identified by MS/
M Sa sH s p2 7( T a b l e 1 ) .T h em u l t i p l es p o t sr e p r e s e n t
unphosphorylated Hsp 27 and its phosphorylated forms
as shown in previous studies [8]. Unlike conventional
protein profiling techniques, CyDye immunoblotting can
simultaneously reveal both total and specific immunode-
tected protein components of a complex protein sample.
The ability of this technique to visualise the entire
expressed proteome combined with immunodetection
represents a significant advance for the identification and
characterisation of proteins separated by 2-DE.
Multiplex detection of proteins by 1-DE with secondary
CyDye- and FITC-conjugated secondary antibodies is
addressed by Gingrich et al. [9]. Although this method
describes the quantitation of protein expression using fluo-
rescent probes it does not incorporate CyDye pre-labelling
and post-labelling experiments on either 1-D or 2-D plat-
forms. Leimgruber et al. [10] demonstrate a technique incor-
porating SYPRO-Ruby staining coupled with CyDye label-
ling and ECL overlaying the total expression profile oftreated
and non-treated groups. While this technique does demon-
strate the ability to view total protein expression before and
after protein transfer to a membrane, it does not address
CyDye-conjugated antibody immunoblotting or the simulta-
neous overlay of total protein expression and decorated pro-
tein candidates as demonstrated here. The overlay of CyDye-
and SYPRO-Ruby-stained images is also questionable, as
often many spots do not correctly align between images [11].
Gel and membrane staining methods such as CBB R-250
(500 ng), silver stain (1 ng), Ponceau-S (5 mg) and the rever-
sible membrane stain Memcode (25 ng) [12], do not offer the
high level of sensitivity afforded by the combined CyDye and
ECL Plex labelling system (1.2 pg). Total protein labelling
with India ink (100 ng) or Colloidal gold (4 ng) although
highly sensitive, must be removed before immunodetection
and therefore limits the comparison between total protein
expression and candidate protein species [13].
The step-wise increase in protein loadings used in this
study reflects the robustness of this protocol. Experimental
replicates (n = 3) for each loading subset, 150, 300 and
600 mg, demonstrate the reproducibility of this method.
Scanning of 150, 300 and 600 mg gels (n = 3) using the
Typhoon 9400 showed no interference between increased
protein loads and calculated fluorescence as pixel volume
was adjusted within a common range (40000–60000 pixels)
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Figure 2. ECL Plex 2-D CyDye blotting. Human left ventricle protein fractions (150 mg( A ) ,3 0 0mg (B), and 600 mg (C)) were primarily CyDye
(Cy3) labelled, focused on pH 3–10 NL IPG strips and subjected to 2-DE using 12% SDS polyacrylamide gels, column 1, (A, B and C). Sepa-
rated proteins were transferred onto NC membranes, column 2. Primary incubation with Hsp 27 mAb was followed by decoration with
CyDye (Cy5)-conjugated secondary antibodies, column 3. Total protein expression combined with specific Hsp 27 protein detection is
overlaid and visualised at specific wavelengths for both Cy Dyes, column 4.
Table 1. Human left ventricle proteins identified by MALDI-TOF/TOF. The multiple immunodetected spots shown in Fig. 2, column 3, were
excised from a silver-stained micro-preparative 2-D gel and identified by MS/MS as Hsp 27 and its isoforms
Spot Protein identity Accession
no.
MASCOT
score
Coverage
%
MS/MS
peptide no.
Sequence Charge
state
1 Heat shock 27-kDa protein P04792 75 36 2 LFDQAFGLPR
LATQSNEITIPVTFESR
1
1
2 Heat shock protein beta 1 P04792 177 66 2 LFDQAFGLPR
LATQSNEITIPVTFESR
1
1
3 Heat shock protein beta 1 P04792 166 61 3 LFDQAFGLPR
QLSSGVSEIR
LATQSNEITIPVTFESR
1
1
1
for all scans. As seen in Fig.2, high protein loading does not
affect the total protein profile, thus enabling the possible
detection of low abundant protein species. The transfer effi-
ciency of CyDye-labelled proteins between gel and mem-
brane was analysed using Progenesis PG240 analysis soft-
ware (Nonlinear Dynamics). Total spot volume from warped
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gel and membrane subsets showed a mean transfer effi-
ciency of between 84 6 9% (150 mg), 74 6 15% (300 mg) and
86 6 6 (600 mg) (n = 3).
CyDye immunoblotting also overcomes many of the
problems associated with conventional DIGE fluorescent
labelling. Labelling of protein mixtures with wavelength-
specific CyDyes results in a small but significant shift in pI
when visualised on a 2-D gel [10]. This problem is com-
pounded by fluorescent-dependent software analysis packa-
ges such as DyCyder and Progenesis. With over 2000 protein
spot species on a single 2-D gel, significant spot comparison
between DIGE and non-DIGE 2-D gels can prove extremely
difficult and can inhibit protein identification in downstream
MS analysis. The combination of DIGE and ECL Plex label-
ling allows the simultaneous comparison of total protein
expression with the specific immunodetected protein of
interest on the same membrane. The immunodetection of
multiple protein targets is also possible with the ECL Plex
system as secondary antibodies labelled with different
CyDyes can be detected at specific wavelengths, suggesting
an added quantitative capability to this approach (www5.
amershambiosciences.com/applic/28401539.pdf.).
In conclusion, we have demonstrated an advanced
CyDye immunoblotting methodology that allows the co-
detection of specific immunolabelled protein(s) in conjunc-
tion with total proteome expression. This technique provides
a simple, rapid and reproducible method for protein con-
firmation following expression software analysis and/or MS
identification.
This material is based on works supported by the Science
Foundation Ireland under Grant No. 04/RP1/B499. The sample
of human ventricular heart tissue was kindly provided, with ethi-
cal approval, by Prof. Marlene Rose (Imperial College, London,
UK).
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